Drag a card by its title · ⚙ to size, swap or remove

The company

Aquestive Therapeutics, Inc.

AQST · Nasdaq

Health CarePharmaceuticalsSetting up

AQST stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 4.4% below that average now. Pharmaceuticals: 35% of its 74 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Setting up
Weeks in an uptrend: out for 2
Industry in uptrend: 35% -4 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $4.7M
Officials’ trades on record: 0
Institutions holding: 178 (+8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

23 Apr – 22 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months16

Buyers · sellers0 · 8

Who	Did	Shares	Traded
Daniel BarberPresident and CEO	sold	25,000at $4.22	15 Oct 2026filed 16 Oct 2026
Daniel BarberPresident and CEO	sold	25,000at $4.82	15 Sep 2026filed 16 Sep 2026
Sherry KorczynskiChief Commercial Officer	sold	8,750at $5.22	9 Sep 2026filed 11 Sep 2026
Daniel BarberPresident and CEO	sold	25,000at $4.29	17 Aug 2026filed 18 Aug 2026
Daniel BarberPresident and CEO	sold	20,369at $4.00	16 Jul 2026filed 17 Jul 2026
Daniel BarberPresident and CEO	sold	4,631at $4.03	15 Jul 2026filed 17 Jul 2026
Julie KropDirector	sold	25,000at $5.02	23 Jun 2026filed 24 Jun 2026
Daniel BarberPresident and CEO	sold	25,000at $4.16	15 Jun 2026filed 16 Jun 2026
Daniel BarberPresident and CEO	sold	8,257at $4.29	15 May 2026filed 18 May 2026
Cassie JungChief Operating Officer	sold	45,791at $4.17	10 Mar 2026filed 11 Mar 2026
Sherry KorczynskiChief Commercial Officer	sold	15,741at $4.17	10 Mar 2026filed 11 Mar 2026
A. Ernest Toth, Jr.Chief Financial Officer	sold	58,254at $4.17	10 Mar 2026filed 11 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders178+8 on the quarter

New · exited27 · 19

Reported value$293.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Bratton Capital Management, L.P.unchanged · filed 11 Aug 2026	9,810,958$40.8M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	8,069,373$33.6M	+560,302+7.5%
RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026	7,426,471$30.9M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026	4,584,533$19.1M	+4,584,533
FEDERATED HERMES, INC.added · filed 12 Aug 2026	3,112,561$12.9M	+172,222+5.9%
STATE STREET CORPadded · filed 7 Aug 2026	2,928,020$12.2M	+381,829+15.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,622,888$10.9M	+214,697+8.9%
SAMSARA BIOCAPITAL, LLCunchanged · filed 14 Aug 2026	2,500,000$10.4M	00.0%
BANK OF AMERICA CORPreduced · filed 14 Aug 2026	1,668,423$6.9M	-736,627−30.6%
Sio Capital Management, LLCreduced · filed 14 Aug 2026	1,486,175$6.2M	-436,712−22.7%